DrugId:  1
1. Name:  5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  2
1. Name:  1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  3
1. Name:  (1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  4
1. Name:  Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  5
1. Name:  D-1-naphthyl-2-acetamido-ethane boronic acid
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  6
1. Name:  Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  7
1. Name:  (2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  8
1. Name:  TH0318
2. Groups:  Investigational
3. Description:  TH0318 is a stabilized analogue of human GLP-1 (glucagon-like peptide-1) under investigation for the treatment of type 2 diabetes.
4. Indication:  Investigated for use/treatment in diabetes mellitus type 1 and 2.
DrugId:  9
1. Name:  4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  10
1. Name:  N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  11
1. Name:  Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  12
1. Name:  1-(1-phenylcyclopentyl)methylamine
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  13
1. Name:  2-{N'-[2-(5-Amino-1-Phenylcarbamoyl-Pentylcarbamoyl)-Hexyl]-Hydrazinomethyl}-Hexanoic Acid(5-Amino-1-Phenylcarbamoyl-Pentyl)-Amide
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  14
1. Name:  (3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  15
1. Name:  (5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  16
1. Name:  D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  17
1. Name:  (3S)-3-(dioxidosulfanyl)-N-[(1E)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  18
1. Name:  2-AMINO-3-(1-HYDROPEROXY-1H-INDOL-3-YL)PROPAN-1-OL
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  19
1. Name:  L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  20
1. Name:  5-aminonaphthalene-1-sulfonic acid
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  21
1. Name:  Tetrahydrocannabivarin
2. Groups:  Investigational
3. Description:  Tetrahydrocannabivarin has been investigated for the treatment of Dyslipidemias and Diabetes Mellitus, Type 2.
4. Indication:  Not Available
DrugId:  22
1. Name:  Pyoverdine-Chromophore
DrugId:  23
1. Name:  Delta-2-Albomycin A1
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  24
1. Name:  RALOXIFENE CORE
2. Groups:  Experimental
3. Description:  Not Available
4. Indication:  Not Available
DrugId:  25
1. Name:  Delcasertib
2. Groups:  Investigational
3. Description:  Not Available
4. Indication:  Investigated for use/treatment in myocardial infarction.
